Press release
miRNA Tools and Services Market to Reach USD 6.42 Billion by 2030 Driven by Expanding Genomics Research & Precision Medicine
miRNA Tools and Services Market
Introduction
The miRNA (microRNA) Tools and Services Market is experiencing significant global growth as miRNAs become central to next-generation diagnostics, therapeutics, and biomarker discovery. MicroRNAs-small, non-coding RNA molecules that regulate gene expression-play a crucial role in cancer, neurological disorders, cardiovascular diseases, immune dysfunctions, and rare genetic conditions.
With rapid advancements in NGS, transcriptomics, and liquid biopsy technologies, demand for miRNA isolation kits, profiling tools, qPCR assays, sequencing platforms, and bioinformatics services is increasing. The market is also fueled by rising pharma/biotech R&D investments and growing adoption of personalized medicine.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73495
Key Takeaways
• Global Market Size (2023): USD 2.85 Billion
• Expected Market Size (2030): USD 6.42 Billion
• CAGR (2024-2030): 12.6%
• Strongest demand coming from oncology research, neurobiology, and cardiovascular biomarker development.
• Leading players include Thermo Fisher Scientific, Qiagen, Illumina, Takara Bio, New England Biolabs (NEB), GeneCopoeia, Agilent Technologies, Horizon Discovery, and LC Sciences.
• Increasing clinical adoption of miRNA-based liquid biopsy tests for early cancer detection.
Market Story
MicroRNAs have emerged as powerful biomarkers due to their stability, specificity, and direct involvement in critical biological pathways. As precision medicine rapidly evolves, miRNA profiling is becoming essential for understanding tumor behavior, predicting drug response, and designing targeted therapies.
Technological innovation continues to push the market forward:
• Advanced miRNA sequencing platforms with single-base precision
• AI-based interpretation tools for transcriptomic data
• Automated RNA isolation & purification systems
• Highly sensitive qRT-PCR kits for low-abundance miRNA targets
• miRNA microarrays for high-throughput screening
• Customized miRNA synthesis & functional assays
Pharmaceutical companies increasingly rely on miRNA tools for target discovery, toxicity prediction, biomarker validation, and clinical trial stratification.
Academic institutions and research labs are scaling up miRNA studies to explore cancer pathways, exosomal miRNAs, and regenerative medicine applications.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73495/mirna-tools-and-services-market
Market Segments
By Product & Service
• miRNA Extraction & Purification Kits
• miRNA qRT-PCR Assays
• miRNA Microarrays
• Next-Generation Sequencing (NGS) Platforms
• miRNA Expression Profiling Services
• Bioinformatics & Data Analysis Software
• miRNA Functional Analysis Tools
By Technology
• PCR-based Methods
• NGS-based miRNA Sequencing
• Microarray-based Profiling
• In Situ Hybridization (ISH)
• Northern Blotting & Immunoassays
By Application
• Oncology (largest & fastest-growing)
• Neurology & Neurodegenerative Diseases
• Cardiology & Metabolic Disorders
• Stem Cell & Regenerative Medicine
• Infectious Diseases
• Drug Discovery & Development
By End User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Clinical Diagnostics Laboratories
• Contract Research Organizations (CROs)
Growth Highlights
• Oncology applications alone account for over 55% of total market revenue.
• NGS-based miRNA sequencing is the fastest-growing technology segment, expanding at a CAGR of ~14%.
• Bioinformatics tools are becoming essential due to explosive growth in miRNA datasets.
Recent Developments
• Thermo Fisher Scientific expanded its TaqMan Advanced miRNA assay portfolio to support higher sensitivity.
• Qiagen launched upgraded miRNA sample prep kits optimized for NGS workflows.
• Illumina released new small-RNA sequencing kits with simplified library prep.
• Takara Bio introduced innovative tools for single-cell miRNA profiling.
• NEB rolled out enhanced ligation-based methods for accurate small RNA sequencing.
• LC Sciences expanded custom miRNA sequencing and bioinformatics service capacity.
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73495
Expert Quote
"miRNAs are redefining the future of molecular diagnostics and drug development. Their role as precise and stable biomarkers is accelerating the transition toward personalized medicine across oncology, neurology, and cardiology."
-Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Market Drivers
• Rising global incidence of cancer and chronic diseases
• Growing focus on precision medicine and targeted therapies
• Increased adoption of miRNA biomarkers for early disease detection
• Advancements in sequencing, qPCR, and microarray technologies
• Expanding pharmaceutical R&D investments
• Growth in liquid biopsy and non-invasive diagnostics
• Strong government funding for genomics and transcriptomics research
Forecast Outlook
The miRNA Tools and Services Market is set to grow robustly, reaching USD 6.42 billion by 2030.
Key growth regions include:
• North America - Largest market due to advanced genomics infrastructure
• Europe - Strong academic and clinical research adoption
• Asia-Pacific - Fastest-growing region (CAGR >13%) driven by rising biotech investments in China, Japan, South Korea, and India
Increasing reliance on multi-omics platforms integrating genomics, transcriptomics, and epigenomics will continue to drive demand for advanced miRNA tools.
Government & Regulatory Initiatives
• FDA encouraging biomarker-based diagnostics and AI-supported assay development
• NIH, NCI, and EU Horizon funding multi-omics and RNA research
• Asia-Pacific governments launching national genomics and precision medicine missions
• Clinical validation requirements for miRNA-based diagnostic tests expanding globally
Conclusion
The miRNA Tools and Services Market is entering a hyper-growth phase driven by advancements in molecular diagnostics, cancer research, and precision medicine. Companies leveraging AI-powered analytics, NGS innovations, and specialized miRNA profiling tools will dominate the next decade of the market.
This report is also available in the following languages : Japanese (miRNAツールおよびサービス市場), Korean (miRNA 도구 및 서비스 시장), Chinese (miRNA工具和服务市场), French (Marché des outils et services miRNA), German (Markt für miRNA-Tools und -Dienstleistungen), and Italian (Mercato degli strumenti e dei servizi miRNA), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73495
Our More Reports:
Non-Viral Transfection Reagents Market
https://exactitudeconsultancy.com/reports/73537/non-viral-transfection-reagents-market
Cell Sorting Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
Pharmaceutical Spray Drying Market
https://exactitudeconsultancy.com/reports/73541/pharmaceutical-spray-drying-market
Bio/Pharmaceutical Outsourcing Market
https://exactitudeconsultancy.com/reports/73627/bio-pharmaceutical-outsourcing-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release miRNA Tools and Services Market to Reach USD 6.42 Billion by 2030 Driven by Expanding Genomics Research & Precision Medicine here
News-ID: 4294371 • Views: …
More Releases from Exactitude Consultancy
Bioprocess Analyzers Market to Reach USD 6.75 Billion by 2030 expanding at a CAG …
Innovation
Sub-Headline: The global Bioprocess Analyzers Market is projected to grow from USD 3.42 billion in 2023 to USD 6.75 billion by 2030, expanding at a CAGR of 9.8%, fueled by the increasing demand for biologics, cell & gene therapies, and real-time process monitoring.
Introduction
The Bioprocess Analyzers Market is witnessing strong acceleration as biopharmaceutical manufacturing becomes increasingly complex, regulated, and data-driven. Bioprocess analyzers-which measure critical parameters such as pH, dissolved oxygen, glucose,…
Alzheimer's Disease in Major Market is projected to grow to USD 16.20 billion by …
The Alzheimer's Disease (AD) market across major regions - United States, EU5 (Germany, France, Italy, Spain, UK), and Japan - is undergoing a major transformation due to the arrival of disease-modifying therapies, biomarker-based diagnostics, and increasing diagnosis rates. In 2023, the major-market AD therapeutics market reached USD 5.95 billion, driven primarily by the commercial uptake of anti-amyloid monoclonal antibodies such as Lecanemab (Leqembi) and Aducanumab in selective patient groups.
The market…
DNA Methylation Market Set to Reach USD 3.85 Billion by 2030,at a CAGR of 11.9%.
Sub-Headline: Driven by breakthroughs in cancer diagnostics, personalized medicine, and liquid biopsy technologies, the global DNA Methylation Market is projected to grow from USD 1.72 billion in 2023 to USD 3.85 billion by 2030, at a CAGR of 11.9%.
Introduction
The DNA Methylation Market is experiencing a major expansion as epigenetics becomes central to cancer detection, drug discovery, and precision medicine. DNA methylation-an essential epigenetic mechanism that regulates gene expression without changing…
Glycated Haemoglobin Testing Market Surges to USD 3.10 Billion by 2030, growing …
Glycated Haemoglobin Testing Market Surges to USD 3.10 Billion by 2030 as Diabetes Cases Accelerate Globally | Abbott, Roche, Siemens Take the Lead
Sub-Headline: Rising diabetes prevalence, rapid adoption of point-of-care devices, and technological advancements in HbA1c analyzers are pushing the global market from USD 1.65 billion in 2023 to USD 3.10 billion by 2030, growing at a CAGR of 9.2%.
Introduction
The Glycated Haemoglobin (HbA1c) Testing Market is witnessing strong global momentum…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
